Publicacións en colaboración con investigadores/as de Hospital de Gran Canaria Dr. Negrin (113)

2024

  1. Combined use of QRISK3 and SCORE2 increases identification of ankylosing spondylitis patients at high cardiovascular risk: Results from the CARMA Project cohort after 7.5 years of follow-up

    Seminars in Arthritis and Rheumatism, Vol. 66

  2. Does remission in systemic lupus erythematosus according to the 2021 DORIS definition match the treating rheumatologist's judgement?

    Rheumatology (Oxford, England), Vol. 63, Núm. 1, pp. 72-78

  3. Malondialdehyde Serum Levels in a Full Characterized Series of 430 Rheumatoid Arthritis Patients

    Journal of Clinical Medicine, Vol. 13, Núm. 3

  4. Mean Platelet Volume Is Related to Cumulative Disease Damage in Patients with Systemic Lupus Erythematosus

    Life, Vol. 14, Núm. 4

  5. SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus based on the RELESSER prospective cohort

    Lupus Science and Medicine, Vol. 11, Núm. 1

  6. The complement system is linked to insulin resistance in patients with systemic lupus erythematosus

    Clinical and experimental rheumatology, Vol. 42, Núm. 1, pp. 115-121

2023

  1. Alpha-Klotho protein in systemic lupus erythematosus

    Clinical and experimental rheumatology, Vol. 41, Núm. 1, pp. 41-47

  2. Anti-TNF vs tocilizumab in refractory uveitic cystoid macular edema due to Behcet's disease. Multicenter study of 49 patients

    Seminars in Arthritis and Rheumatism, Vol. 58

  3. Blood Composite Scores in Patients with Systemic Lupus Erythematosus

    Biomedicines, Vol. 11, Núm. 10

  4. Central nervous system involvement in systemic lupus erythematosus: Data from the Spanish Society of Rheumatology Lupus Register (RELESSER)

    Seminars in Arthritis and Rheumatism, Vol. 58

  5. Circulating interleukin-6 and cardiovascular disease risk in patients with rheumatoid arthritis with low disease activity due to active therapy

    Clinical and experimental rheumatology, Vol. 41, Núm. 7, pp. 1537-1543

  6. Disease Activity Is More Associated with IL-1 Than with IL-6 in Patients with Rheumatoid Arthritis

    Life, Vol. 13, Núm. 1

  7. Disease activity in patients with rheumatoid arthritis increases serum levels of apolipoprotein C-III

    Clinical and experimental rheumatology, Vol. 41, Núm. 1, pp. 67-73

  8. Does expert opinion match the definition of lupus low disease activity state? Prospective analysis of 500 patients from a Spanish multicentre cohort

    Rheumatology (Oxford, England), Vol. 62, Núm. 3, pp. 1162-1169

  9. Full characterization of the three pathways of the complement system in patients with systemic lupus erythematosus

    Frontiers in Immunology, Vol. 14

  10. HDL Cholesterol Efflux and the Complement System Are Linked in Systemic Lupus Erythematosus

    Journal of Clinical Medicine, Vol. 12, Núm. 16

  11. Long-term retention of golimumab treatment in clinical practice in a large cohort of patients with rheumatoid arthritis, axial spondyloarthritis and psoriatic arthritis

    Musculoskeletal Care, Vol. 21, Núm. 1, pp. 189-197

  12. Mean Platelet Volume in a Series of 315 Patients with Rheumatoid Arthritis: Relationship with Disease Characteristics, including Subclinical Atherosclerosis and Cardiovascular Comorbidity

    Diagnostics, Vol. 13, Núm. 20

  13. Pregnancy outcomes in 1869 pregnancies in a large cohort from the Spanish Society of Rheumatology Lupus Register (RELESSER)

    Seminars in Arthritis and Rheumatism, Vol. 61

  14. Red Cell Distribution Width Association with Subclinical Cardiovascular Disease in Patients with Rheumatoid Arthritis

    Journal of Clinical Medicine, Vol. 12, Núm. 20